Sign in

    Susannah Ludwig

    Research Analyst at Bernstein

    Susannah Ludwig is a Research Analyst at Bernstein specializing in the EU Consumer Medical Technologies sector, with coverage including companies such as Alcon and Sonova. She has initiated and upgraded company ratings, notably initiating coverage of Alcon with an Outperform rating and setting a price target of $94.40, and upgrading Sonova with a price target of CHF 278, reflecting strong analytical performance. Ludwig joined Bernstein in 2019 and has participated in earnings calls for companies like Alcon AG and GNNDY, demonstrating subject matter expertise and active sector engagement. Specific performance metrics such as success rates, TipRanks rankings, or professional licensing credentials are not publicly available.

    Susannah Ludwig's questions to ALCON (ALC) leadership

    Susannah Ludwig's questions to ALCON (ALC) leadership • Q2 2025

    Question

    Susannah Ludwig of Bernstein asked for more detail on the weak growth in the consumables business, questioning which regions were most affected and whether the subdued trend would continue, as well as the price contribution in Q2.

    Answer

    CEO David Endicott confirmed that the consumables business performance is a direct proxy for the slower procedural market. He noted the slowdown was global, affecting both U.S. and international markets, and that similar trends are expected in the second half of the year, consistent with guidance. He also stated there was no material change in price contribution versus Q1.

    Ask Fintool Equity Research AI

    Susannah Ludwig's questions to GNNDY leadership

    Susannah Ludwig's questions to GNNDY leadership • Q3 2023

    Question

    Inquired about the competitive impact of PC players entering the enterprise headset space, the percentage of sales from top accounts susceptible to bundling, and competitive dynamics in the Hearing market during Q3.

    Answer

    The company has so far defended its position well against PC players and bundling attempts, which are mostly seen in top accounts. They did not disclose the sales percentage from these accounts. In Hearing, they believe they continued to gain market share in Q3 and did not observe a dramatic change in competitive dynamics compared to Q2.

    Ask Fintool Equity Research AI